TER Stock Analysis: Teradyne | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 62.336m USD | 12M Return: 176.4% | US8807701029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 922M
EPS Trend: 77.5%
Qual. Beats: 4
Rev. Trend: 80.2%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Teradyne, Inc. (NASDAQ: TER) is a U.S.-headquartered company that designs, develops, manufactures, and sells automated test systems and robotics products, operating across the United States, Asia Pacific, Europe, the Middle East, and Africa. Founded in 1960 and based in North Reading, Massachusetts, Teradyne is classified within the Semiconductor Materials & Equipment sub-industry, a capital-intensive sector whose demand is closely tied to global semiconductor manufacturing cycles and capital spending by chip producers.
The company reports through three segments: Semiconductor Test, Robotics, and Other. The Semiconductor Test segment provides wafer-level, device-package, and system-level testing equipment for automotive, industrial, communications, consumer, smartphone, cloud, computing, and electronic gaming applications, with platforms such as FLEX, J750, Magnum, and ETS serving integrated device manufacturers, fabless companies, foundries, and assembly/test subcontractors. Semiconductor test equipment plays a critical role in verifying chip functionality and yield, making it a required step before devices reach end markets.
The Robotics segment supplies collaborative robotic arms and autonomous mobile robots to manufacturing, logistics, and industrial customers, positioning Teradyne in the growing industrial automation market. The Other segment covers defense/aerospace test, circuit-board test, wireless test systems, and silicon photonics testing. Teradyne also maintains a strategic collaboration with Tokyo Electron Limited to develop a test cell solution targeting AI and data center device screening applications.
- AI test demand expands via Tokyo Electron partnership
- China smartphone weakness pressures volume Semi Test revenue
- Robotics segment growth slows on industrial automation capex pullback
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: 28.06% < 20% (prev 32.12%; Δ -4.07% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.06b > Net Income 1.15b |
| Net Debt (-254.7m) to EBITDA (1.52b): -0.17 < 3 |
| Current Ratio: 2.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.7m) vs 12m ago -2.11% < -2% |
| Gross Margin: 59.24% > 18% (prev 59.14%; Δ 0.11% > 0.5%) |
| Asset Turnover: 102.8% > 50% (prev 75.17%; Δ 27.60% > 0%) |
| Interest Coverage Ratio: 108.2 > 6 (EBIT TTM 1.39b / Interest Expense TTM 12.8m) |
| A: 0.25 (Total Current Assets 2.37b - Total Current Liabilities 1.11b) / Total Assets 4.93b |
| B: 0.28 (Retained Earnings 1.40b / Total Assets 4.93b) |
| C: 0.32 (EBIT TTM 1.39b / Avg Total Assets 4.34b) |
| D: 2.37 (Book Value of Equity 3.44b / Total Liabilities 1.45b) |
| Altman-Z'' = 7.23 = AAA |
| DSRI: 1.62 (Receivables 1.11b/433.0m, Revenue 4.46b/2.83b) |
| GMI: 1.00 (GM 59.14% / 59.24%) |
| AQI: 0.90 (AQ_t 0.37 / AQ_t-1 0.41) |
| SGI: 1.58 (Revenue 4.46b / 2.83b) |
| TATA: 0.02 (NI 1.15b - CFO 1.06b) / TA 4.93b) |
| Beneish M = -2.16 (Cap -4..+1) = BB |
As of October 13, 2026, the stock is trading at USD 383.85 with a total of 2,729,400 shares traded. Over the past week, the price has changed by -13.65%, over one month by +16.60%, over three months by +12.57% and over the past year by +176.43%.
Current recommended Stop Loss: 335.00 (which is 12.7% or 2.4 ATR below the current price).
Teradyne has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy TER.
- StrongBuy: 11
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 446.5 | 16.3% |
P/E Trailing = 54.7692
P/E Forward = 30.6748
P/S = 13.9641
P/B = 18.1346
P/EG = 0.7296
Revenue TTM = 4.46b USD
EBIT TTM = 1.39b USD
EBITDA TTM = 1.52b USD
Long Term Debt = 82.9m USD (estimated: total debt 100.1m - short term 17.3m)
Short Term Debt = 17.3m USD (from shortTermDebt, last quarter)
Debt = 100.1m USD (from shortLongTermDebtTotal, last quarter) (leases 100.1m already included)
Net Debt = -254.7m USD (calculated: Debt 100.1m - CCE 354.8m)
Enterprise Value = 62.1b USD (62.3b + Debt 100.1m - CCE 354.8m)
Interest Coverage Ratio = 108.2 (Ebit TTM 1.39b / Interest Expense TTM 12.8m)
EV/FCF = 77.61x (Enterprise Value 62.1b / FCF TTM 799.9m)
FCF Yield = 1.29% (FCF TTM 799.9m / Enterprise Value 62.1b)
FCF Margin = 17.92% (FCF TTM 799.9m / Revenue TTM 4.46b)
Net Margin = 25.77% (Net Income TTM 1.15b / Revenue TTM 4.46b)
Gross Margin = 59.24% ((Revenue TTM 4.46b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 59.79% (prev 60.89%)
Tobins Q-Ratio = 12.60 (Enterprise Value 62.1b / Total Assets 4.93b)
Interest Expense / Debt = 12.83% (Interest Expense 12.8m / Debt 100.1m)
Taxrate = 13.70% (183.4m / 1.34b)
NOPAT = 1.20b (EBIT 1.39b * (1 - 13.70%))
Current Ratio = 2.12 (Total Current Assets 2.37b / Total Current Liabilities 1.11b)
Debt / Equity = 0.03 (Debt 100.1m / totalStockholderEquity, last quarter 3.44b)
Debt / EBITDA = -0.17 (Net Debt -254.7m / EBITDA 1.52b)
Debt / FCF = -0.32 (Net Debt -254.7m / FCF TTM 799.9m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.48% (Net Income 1.15b / Total Assets 4.93b)
RoE = 38.04% (Net Income TTM 1.15b / Total Stockholder Equity 3.02b)
RoCE = 44.77% (EBIT 1.39b / Capital Employed (Equity 3.02b + L.T.Debt 82.9m))
RoIC = 33.28% (NOPAT 1.20b / Invested Capital 3.61b)
WACC = 15.89% (E(62.3b)/V(62.4b) * Re(15.90%) + D(100.1m)/V(62.4b) * Rd(12.83%) * (1-Tc(0.14)))
Discount Rate = 15.90% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -90.85 | Cagr: -1.29%
[DCF] Terminal Value 57.42% ; FCFF base≈707.5m ; Y1≈811.1m ; Y5≈1.19b
[DCF] Fair Price = 50.31 (EV 7.61b - Net Debt -254.7m = Equity 7.87b / Shares 156.3m; r=15.89% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 77.49 | EPS CAGR: 30.26% | SUE: 2.57 | # QB: 4
Revenue Correlation: 80.23 | Revenue CAGR: 15.31% | SUE: 2.90 | # QB: 4
EPS current Quarter (2026-09-30): EPS=2.05 | Chg30d=+42.05% | Revisions=+83% | Analysts=15
EPS current Year (2026-12-31): EPS=9.09 | Chg30d=+0.00% | Revisions=+84% | GrowthEPS=+129.6% | GrowthRev=+61.2%
EPS next Year (2027-12-31): EPS=11.65 | Chg30d=+0.00% | Revisions=+74% | GrowthEPS=+28.2% | GrowthRev=+21.8%
[Analyst] Revisions Ratio: +90% (up=46, down=1)